How to Get Ibrance (Palbociclib) Covered by Cigna in Pennsylvania: Prior Authorization Guide and Appeals Process
Quick Answer: Getting Ibrance (Palbociclib) Covered by Cigna in Pennsylvania
Cigna requires prior authorization for Ibrance (palbociclib) with step therapy mandating trials of preferred CDK4/6 inhibitors like Kisqali or Verzenio first. Key requirements: HR+/HER2- pathology report, documented failure/intolerance of formulary alternatives, and combination with endocrine therapy. If